13F
中

INBX INHIBRX BIOSCIENCES INC

2026Q1 · CUSIP 45720N103 · Sector: Healthcare & Biotech

Fading · Price holds, watch
Holders
134
Δ holders QoQ
-3
Breadth percentile
Top 73%
Whale holders
77
Δ whales
+2
Inst. holding value
$854M
New positions
25
Closed positions
28
Price momentum (1Q)
+34.3%
Put / Call
3/10

Breadth history (34 quarters)

2024Q3: Δ+10 · h=97 2024Q4: Δ+5 · h=102 2025Q1: Δ-8 · h=94 2025Q2: Δ-4 · h=90 2025Q3: Δ+13 · h=103 2025Q4: Δ+34 · h=137 2026Q1: Δ-3 · h=134 2024Q3: holders=97 2024Q4: holders=102 2025Q1: holders=94 2025Q2: holders=90 2025Q3: holders=103 2025Q4: holders=137 2026Q1: holders=134 -34 -17 +0 +17 +34 81113144 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 16% +34.3% —

Options Sentiment

Put holders
3
QoQ: -3
Call holders
10
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-8.39
EPS YoY
-107.3%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2023-06-30: EPS -4.31 2023-09-30: EPS -4.39 2024-03-31: EPS -5.77 2024-06-30: EPS 125.48 2024-09-30: EPS -2.84 2024-12-31: EPS -4.25 2025-03-31: EPS -2.80 2025-06-30: EPS -1.85 2025-09-30: EPS -2.28 2025-12-31: EPS -2.11 2026-03-31: EPS -2.15 -6.35 65.84 138.03 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 0 2024-06-30: PE 0.12024-09-30: PE 0.12024-12-31: PE 0.12025-03-31: PE 0.1 0 0 0 2023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)